BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30765668)

  • 1. [Postoperative Recurrence of Pancreatic Cancer Successfully Treated with the Gemcitabine plus Oxaliplatin Regimen Resulting in Long-Term Survival-ACase Report].
    Makino H; Kametaka H; Fukada T; Akiyama T; Saitou M; Tabe S; Okura R; Oya M; Seike K; Yoshitomi H; Miyazaki M
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):142-144. PubMed ID: 30765668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.
    Hiyoshi M; Nanashima A; Wada T; Tsuchimochi Y; Hamada T; Yano K; Imamura N; Fujii Y
    Clin J Gastroenterol; 2017 Dec; 10(6):551-557. PubMed ID: 29086227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy].
    Okada T; Sakurai N; Yamamoto K; Motoi F; Kakizaki Y; Tamura G; Unno M; Iizawa H
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):135-7. PubMed ID: 22241369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Pathological Complete Response Following Neoadjuvant Chemotherapy with Gemcitabine plus Nab-Paclitaxel in Borderline Resectable Pancreatic Cancer].
    Ohno N; Ishida M; Ohnishi K; Sawai K; Tabata S; Deguchi M; Kitajima T; Kaizaki Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1735-1738. PubMed ID: 29394759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Clinical Efficacy of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Carcinoma--Report of Two Cases Treated by Curative Pancreatectomy with Portal Vein Resection after Neoadjuvant Chemotherapy].
    Imamura T; Ikoma H; Morimura R; Hatakeyama T; Kosuga T; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2379-81. PubMed ID: 26805370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Curatively Resected Locally Advanced Cancer of the Pancreatic Body Treated by Distal Pancreatectomy with En Bloc Celiac Axis Resection after Preoperative Intensive Treatment].
    Kim Y; Hoshino H; Kakita N; Yamasaki M; Hosoda Y; Nishino M; Okano M; Kawada J; Okuyama M; Tsujinaka T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2068-2070. PubMed ID: 28133224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total pancreatoduodenectomy en bloc with superior mesenteric artery and vein resection after gemcitabine and nab-paclitaxel neoadjuvancy.
    Vicente E; Quijano Y; Ielpo B; Duran H
    Surg Oncol; 2017 Sep; 26(3):276-277. PubMed ID: 29804945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas].
    Obayashi K; Ohwada S; Sunose Y; Yamamoto K; Igarashi R; Hamada K; Takeyoshi I; Horiuchi R
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1915-7. PubMed ID: 19011342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GEM + nab-PTX Therapy for Pancreatic Body Cancer cStage IVb for Conversion Surgery: A Case Report.
    Yoshii H; Izumi H; Abe R; Tajiri T; Mukai M; Nomura E; Makuuchi H
    Tokai J Exp Clin Med; 2019 Dec; 44(4):85-89. PubMed ID: 31768996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of pancreatic cancer with celiac trunk and common hepatic artery invasion successfully resected after gemcitabine+S-1therapy].
    Katoh R; Takeyoshi I; Sunose Y; Yoshinari D; Totsuka O; Toya H; Ogawa H; Hirai K
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):273-5. PubMed ID: 22333642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancer.
    Yoshitomi H; Sakai N; Kagawa S; Takano S; Ueda A; Kato A; Furukawa K; Takayashiki T; Kuboki S; Miyzaki M; Ohtsuka M
    Langenbecks Arch Surg; 2019 Jun; 404(4):451-458. PubMed ID: 30868241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
    Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
    Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Pathological Complete Response Induced by Preoperative Chemotherapy with Gemcitabine plus Nab-Paclitaxel in a Patient with Pancreatic Cancer on Hemodialysis].
    Okazaki M; Tajima H; Ohbatake Y; Terai S; Nakanuma S; Okamoto K; Sakai S; Makino I; Kinoshita J; Nakamura K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Ohta T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2162-2164. PubMed ID: 30692318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after distal pancreatectomy with celiac axis resection and hepatic artery reconstruction in the setting of locally advanced unresectable pancreatic cancer.
    Shibata Y; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Arihiro K; Takahashi S
    Clin J Gastroenterol; 2022 Jun; 15(3):635-641. PubMed ID: 35352239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study.
    Fortune BE; Li X; Kosuri KV; Weatherby LM; Thomas JP; Bekaii-Saab TS
    Oncology; 2009; 76(5):333-7. PubMed ID: 19307739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
    Louvet C; Labianca R; Hammel P; Lledo G; Zampino MG; André T; Zaniboni A; Ducreux M; Aitini E; Taïeb J; Faroux R; Lepere C; de Gramont A; ;
    J Clin Oncol; 2005 May; 23(15):3509-16. PubMed ID: 15908661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [R0 Resection by Distal Pancreatectomy with En Bloc Celiac Axis Resection after Down-Staging by FOLFIRINOX Therapy in a Case of Pancreas Cancer--Report of a Case].
    Makino H; Kametaka H; Fukada T; Seike K; Koyama T; Hasegawa A
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1644-6. PubMed ID: 26805124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Initially Locally Advanced Pancreatic Cancer Curatively Resected after Carbon-Ion Radiotherapy with Gemcitabine].
    Miyazaki K; Hayashi H; Ishida M; Ohtsuka H; Mizuma M; Nakagawa K; Morikawa T; Motoi F; Kamei T; Shinoto M; Yamada S; Takiyama H; Unno M
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2266-2268. PubMed ID: 33468929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Conversion Surgery after Long-Term Chemotherapy for Pancreatic Cancer with Peritoneal Metastasis].
    Enoki M; Gotoh K; Sakai K; Toshiyama R; Yanagisawa K; Kawai K; Miyo M; Takahashi Y; Hamakawa T; Doi T; Takeno A; Katoh T; Takami K; Hirao M
    Gan To Kagaku Ryoho; 2023 Jan; 50(1):87-89. PubMed ID: 36759995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
    Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.